Zicam Maker Coughs Up $4.5M to Settle Shareholder Action
Matrixx Initiatives Inc., maker of the cold remedy Zicam, has agreed to pay $4.5 million to settle an eight-year-old class action alleging the company violated securities laws by concealing reports that...To view the full article, register now.
Already a subscriber? Click here to view full article